As obesity clinical trials evolve, there is a growing emphasis on how decentralisation and new technologies can play a role.

Detailed price information for Bio-Path Holdings (BPTH-Q) from The Globe and Mail including charting and trades.

The KAER framework is designed to help primary care providers partner with older adults to engage in shared decision-making ...

A Carnegie Mellon University-led team of researchers has secured an award of up to $34.9 million(opens in new window) from ...

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's ...

Parcel Health stands out as a key player in providing innovative packaging solutions for compounding pharmacies. Parcel Health's eco-friendly paper pill bottles ensure the stability and integrity of ...

The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to ...

Raising awareness about breast cancer encourages women to be proactive about regular check-ups and healthy habits, which are ...

In a recent study explained in Medical News Today, weight loss surgery can significantly decrease the progression of kidney ...

Bio-Path Holdings, Inc., (NASDAQ:BPTH) stock is trading higher on Tuesday with a strong session volume of 25.89 million ...

Like women, men should check their chests regularly for symptoms. As with all cancers, early detection is key. However, a ...